Enovis Corporation (NYSE:ENOV) Q3 2022 Earnings Conference Call November 2, 2022 8:00 AM ET

Company Participants

Derek Leckow - Vice President, Investor Relations

Matt Trerotola - Chief Executive Officer

Chris Hix - Executive Vice President & Chief Financial Officer

Ben Berry - Interim Chief Financial Officer

Conference Call Participants

Vijay Kumar - Evercore ISI

Vik Chopra - Wells Fargo

Matt Mishan - KeyBanc

Xuyang Li - Jefferies

Kyle Rose - Canaccord

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Enovis Third Quarter 2022 Earnings Call.

I would now like to turn the call over to Derek Leckow, Vice President of Investor Relations. Please go ahead.

Derek Leckow

Thank you. Good morning, everyone. Thank you for joining us today for our third quarter results conference call. I'm Derek Leckow, Vice President of Investor Relations and joining me on the call today are Matt Trerotola, CEO; and Chris Hix, Executive Vice President and CFO; and Ben Berry, who we previously announced will serve as Enovis' CFO when Chris retires at the end of the year.

Our earnings release was issued earlier this morning and is available in the Investor Relations section of our website, enovis.com. We'll be using a slide presentation in today's call, which can also be found on our website. Both the audio and slide presentation of this call will be archived on the website later today.

During this call, we'll be making some forward-looking statements about our beliefs and estimates regarding future events and results. These forward-looking statements are subject to risks and uncertainties, including those set forth in the safe harbor language in today's earnings release and in our filings with the SEC. Actual results may differ materially from any forward-looking statements that we make today. The forward-looking statements speak only as of today, and we do not assume any obligation or intent to update them except as required by law.

With respect to any non-GAAP financial measures referenced during the call today, the accompanying reconciliation information relating to those measures can be found in our press release and in the appendix of today's slide presentation.

With that, let me turn it over to Matt on Slide three?

Matt Trerotola

Thanks Derek. I am pleased to discuss our great operating and strategic progress this quarter. We had strong growth and are demonstrating clear strides toward our strategic goal of sustainable high single digit organic growth. Our growth is supported by an innovation engine that continues to produce exciting new technologies and solutions to improve patient outcomes and healthcare workflows.